.32 saved for the time being. That was an impressive reversal. Let's see if it stalls at .40. I don't think the oncology angle is smoke and mirrors.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game